Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin Yi

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Science Advances|July 20, 2022
Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeuticsTimothy P Cripe, Brian Hutzen, Mark A Currier, et al.
Annals of Surgery|December 15, 2015
Postoperative Showering for Clean and Clean-contaminated Wounds: A Prospective, Randomized Controlled TrialPei-Yin Hsieh, Kuen-Yuan Chen, Hsuan-Yu Chen, et al.
Molecular Therapy Oncolytics|April 28, 2016
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivityJennifer L Leddon, Chun-Yu Chen, Mark A Currier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2013
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cellsMark A Currier, Francis K Eshun, Allyson Sholl, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Science Advances|July 20, 2022
Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeuticsTimothy P Cripe, Brian Hutzen, Mark A Currier, et al.
Annals of Surgery|December 15, 2015
Postoperative Showering for Clean and Clean-contaminated Wounds: A Prospective, Randomized Controlled TrialPei-Yin Hsieh, Kuen-Yuan Chen, Hsuan-Yu Chen, et al.
Molecular Therapy Oncolytics|April 28, 2016
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivityJennifer L Leddon, Chun-Yu Chen, Mark A Currier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2013
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cellsMark A Currier, Francis K Eshun, Allyson Sholl, et al.
Pageof 18